- Home
- VST vs ALC Comparison
VST vs ALC Comparison
Compare VST & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VST
- ALC
- Stock Information
- Founded
- VST 1882
- ALC 1945
- Country
- VST United States
- ALC Switzerland
- Employees
- VST N/A
- ALC N/A
- Industry
- VST Electric Utilities: Central
- ALC Ophthalmic Goods
- Sector
- VST Utilities
- ALC Health Care
- Exchange
- VST Nasdaq
- ALC Nasdaq
- Market Cap
- VST 38.0B
- ALC 43.0B
- IPO Year
- VST N/A
- ALC N/A
- Fundamental
- Price
- VST $192.20
- ALC $87.91
- Analyst Decision
- VST Strong Buy
- ALC Buy
- Analyst Count
- VST 9
- ALC 10
- Target Price
- VST $178.44
- ALC $107.00
- AVG Volume (30 Days)
- VST 4.9M
- ALC 1.5M
- Earning Date
- VST 08-07-2025
- ALC 08-19-2025
- Dividend Yield
- VST 0.47%
- ALC 0.25%
- EPS Growth
- VST 291.00
- ALC 6.66
- EPS
- VST 6.38
- ALC 2.25
- Revenue
- VST $18,103,000,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- VST $17.71
- ALC $6.22
- Revenue Next Year
- VST $8.35
- ALC $7.16
- P/E Ratio
- VST $30.11
- ALC $38.98
- Revenue Growth
- VST 35.02
- ALC 3.80
- 52 Week Low
- VST $66.50
- ALC $80.48
- 52 Week High
- VST $199.84
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- VST 67.21
- ALC 49.95
- Support Level
- VST $180.51
- ALC $86.94
- Resistance Level
- VST $198.20
- ALC $89.52
- Average True Range (ATR)
- VST 6.48
- ALC 1.29
- MACD
- VST -0.40
- ALC 0.42
- Stochastic Oscillator
- VST 78.22
- ALC 66.34
About VST Vistra Corp.
Vistra Energy is one of the largest power producers and retail energy providers in the US. Following the 2024 Energy Harbor acquisition, Vistra owns 41 gigawatts of nuclear, coal, natural gas, solar, and energy storage assets. Its retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016. It acquired Dynegy in 2018.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.